Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02384265 · ClinicalTrials.gov registry record · NA

Financial Incentives and Text Messaging to Improve African American Womens' Glycemic Control

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
41
Enrollment target

NCT02384265 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 41 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02384265, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
41 participants
Enrollment target

Study Summary

Diabetes is a major public health problem that is associated with substantial health disparities for African American women compared to African American men or white men and women. This project will incorporate a) new technology whose use is high among African Americans (cell phone text message reminders), b) support from social networks, and c) strategies from the emerging field of behavioral economics to encourage and support self care behaviors that lead to improvements in diabetes control. In Stage I of the study, the investigators conducted focus groups with women with diabetes and their family members and friends. The investigators used information from these groups to work with a team of community partners to develop recruitment protocols, prepare study documents (including flyers, Frequently Asked Questions sheets, and informed consent forms), and finalize participant surveys. In the next phase of the study the investigators will evaluate ways that friends and family members can use direct support and text messages to improve control of blood sugar for African American women with type 2 diabetes. A team of three people--the Person With Diabetes (PWD) and 2 friends or family members, also known as the Support Team Members (STMs)--will be assigned at random to one of two groups to compare approaches to improving control of blood sugar. Each team will receive information and resources on improving diabetes control and will be linked by a text messaging program. The intervention team will receive additional text messaging support that may help them improve the PWD's diabetes control.

Interventions

  • BEHAVIORAL IM/SMS + Incentive Condition

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2012-06-21
Est. Completion 2021-12-31
Phase NA

What the Registry Record Tells You About NCT02384265

The ClinicalTrials.gov registry entry for NCT02384265 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which IM/SMS + Incentive Condition is the first listed.

NCT02384265 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02384265 about?

NCT02384265 is a clinical study titled "Financial Incentives and Text Messaging to Improve African American Womens' Glycemic Control". Diabetes is a major public health problem that is associated with substantial health disparities for African American women compared to African American men or white men and women. This project will incorporate a) new technology whose use is high among African Americans (cell phone text message remi...

What is the current status of trial NCT02384265?

This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2012-06-21. Estimated completion is 2021-12-31.

What interventions are being tested in trial NCT02384265?

The interventions under investigation include: IM/SMS + Incentive Condition (BEHAVIORAL).

Who is sponsoring clinical trial NCT02384265?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.